Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?

Kehoe PG, Wilcock GK.

Lancet Neurol. 2007 Apr;6(4):373-8. Review.

PMID:
17362841
2.

[Angiotensin converting enzyme and Alzheimer's disease].

Kugaevskaia EV.

Biomed Khim. 2013 Jan-Feb;59(1):5-24. Review. Russian.

PMID:
23650720
3.

Current status of renin-aldosterone angiotensin system-targeting anti-hypertensive drugs as therapeutic options for Alzheimer's disease.

Ashby EL, Kehoe PG.

Expert Opin Investig Drugs. 2013 Oct;22(10):1229-42. doi: 10.1517/13543784.2013.812631. Epub 2013 Jun 26. Review.

PMID:
23800077
4.

The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential.

Takeda S, Sato N, Ogihara T, Morishita R.

Front Biosci. 2008 Jan 1;13:2253-65. Review.

PMID:
17981707
5.

[Novel Abeta-converting activity of angiotensin-converting enzyme and its role in Alzheimer's disease].

Zou K, Michikawa M, Komano H.

Seikagaku. 2010 Dec;82(12):1120-4. Review. Japanese. No abstract available.

PMID:
21348266
6.

The brain RAS and Alzheimer's disease.

Wright JW, Harding JW.

Exp Neurol. 2010 Jun;223(2):326-33. doi: 10.1016/j.expneurol.2009.09.012. Epub 2009 Sep 24. Review.

PMID:
19782074
7.

Do angiotensin receptor blockers prevent Alzheimer's disease?

Hajjar I, Rodgers K.

Curr Opin Cardiol. 2013 Jul;28(4):417-25. doi: 10.1097/HCO.0b013e3283620745. Review.

PMID:
23703253
8.
9.

[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].

Abassi Z, Armaly Z, Nakhoul F, Hoffman A.

Harefuah. 2008 Jun;147(6):536-42, 573. Review. Hebrew.

PMID:
18693632
10.

Pathophysiological Links Among Hypertension and Alzheimer's Disease.

Carnevale D, Perrotta M, Lembo G, Trimarco B.

High Blood Press Cardiovasc Prev. 2016 Mar;23(1):3-7. doi: 10.1007/s40292-015-0108-1. Epub 2015 Jun 9. Review.

PMID:
26054481
11.

Angiotensins in Alzheimer's disease - friend or foe?

Kehoe PG, Miners S, Love S.

Trends Neurosci. 2009 Dec;32(12):619-28. doi: 10.1016/j.tins.2009.07.006. Epub 2009 Sep 30. Review.

PMID:
19796831
13.

Angiotensin and Alzheimer's disease: therapeutic prospects.

Gard PR, Rusted JM.

Expert Rev Neurother. 2004 Jan;4(1):87-96. Review.

PMID:
15853619
14.
15.
16.

The renin-angiotensin system and antihypertensive drugs in Alzheimer's disease: current standing of the angiotensin hypothesis?

Kehoe PG, Passmore PA.

J Alzheimers Dis. 2012;30 Suppl 2:S251-68. doi: 10.3233/JAD-2012-111376. Review.

PMID:
22330821
17.

Peptides as targets for antihypertensive drug development.

Hedner T, Sun X, Junggren IL, Pettersson A, Edvinsson L.

J Hypertens Suppl. 1992 Dec;10(7):S121-32. Review.

PMID:
1291647
18.
19.

The molecular pathology of Alzheimer's disease.

Harrington CR.

Neuroimaging Clin N Am. 2012 Feb;22(1):11-22, vii. doi: 10.1016/j.nic.2011.11.003. Review.

PMID:
22284730
20.

Recent changes in the landscape of combination RAS blockade.

Epstein BJ, Smith SM, Choksi R.

Expert Rev Cardiovasc Ther. 2009 Nov;7(11):1373-84. doi: 10.1586/erc.09.127. Review.

PMID:
19900020

Supplemental Content

Support Center